These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 14606338)

  • 1. Infections due to non-neoformans cryptococcal species.
    McCurdy LH; Morrow JD
    Compr Ther; 2003; 29(2-3):95-101. PubMed ID: 14606338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adaptation to Fluconazole via Aneuploidy Enables Cross-Adaptation to Amphotericin B and Flucytosine in Cryptococcus neoformans.
    Yang F; Gritsenko V; Lu H; Zhen C; Gao L; Berman J; Jiang YY
    Microbiol Spectr; 2021 Oct; 9(2):e0072321. PubMed ID: 34585947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluconazole-resistant Cryptococcus neoformans isolated from an immunocompetent patient without prior exposure to fluconazole.
    Orni-Wasserlauf R; Izkhakov E; Siegman-Igra Y; Bash E; Polacheck I; Giladi M
    Clin Infect Dis; 1999 Dec; 29(6):1592-3. PubMed ID: 10585832
    [No Abstract]   [Full Text] [Related]  

  • 4. Current approach to the acute management of cryptococcal infections.
    Powderly WG
    J Infect; 2000 Jul; 41(1):18-22. PubMed ID: 11041709
    [No Abstract]   [Full Text] [Related]  

  • 5. [Tenosynovitis caused by Cryptococcus neoformans in a patient with AIDS].
    Fernández CM; Enrique Morano L; Angel Montero L
    Enferm Infecc Microbiol Clin; 2001; 19(6):285-6. PubMed ID: 11440675
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy of Oral Encochleated Amphotericin B in a Mouse Model of Cryptococcal Meningoencephalitis.
    Lu R; Hollingsworth C; Qiu J; Wang A; Hughes E; Xin X; Konrath KM; Elsegeiny W; Park YD; Atakulu L; Craft JC; Tramont EC; Mannino R; Williamson PR
    mBio; 2019 May; 10(3):. PubMed ID: 31138748
    [No Abstract]   [Full Text] [Related]  

  • 7. Systemic humicolus cryptococcosis.
    Shinde SM; Vanarse KS; Pandit AN
    Indian Pediatr; 2004 Nov; 41(11):1162-4. PubMed ID: 15591670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of azole resistance during fluconazole maintenance therapy for AIDS-associated cryptococcal disease.
    Friese G; Discher T; Füssle R; Schmalreck A; Lohmeyer J
    AIDS; 2001 Nov; 15(17):2344-5. PubMed ID: 11698718
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy of amphotericin B in combination with flucytosine against flucytosine-susceptible or flucytosine-resistant isolates of Cryptococcus neoformans during disseminated murine cryptococcosis.
    Schwarz P; Dromer F; Lortholary O; Dannaoui E
    Antimicrob Agents Chemother; 2006 Jan; 50(1):113-20. PubMed ID: 16377675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraocular cryptococcoma.
    Wykoff CC; Albini TA; Couvillion SS; Dubovy SR; Davis JL
    Arch Ophthalmol; 2009 May; 127(5):700-2. PubMed ID: 19433726
    [No Abstract]   [Full Text] [Related]  

  • 11. Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS. A randomized trial.
    Larsen RA; Leal MA; Chan LS
    Ann Intern Med; 1990 Aug; 113(3):183-7. PubMed ID: 2197908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cryptococcus neoformans infection.
    Paterson DL; Singh N
    Liver Transpl; 2002 Sep; 8(9):846-7. PubMed ID: 12200789
    [No Abstract]   [Full Text] [Related]  

  • 13. Cryptococcus genetic diversity and mixed infections in Ivorian HIV patients: A follow up study.
    Kassi FK; Drakulovski P; Bellet V; Roger F; Chabrol A; Krasteva D; Doumbia A; Landman R; Kakou A; Reynes J; Delaporte E; Menan HEI; Bertout S
    PLoS Negl Trop Dis; 2019 Nov; 13(11):e0007812. PubMed ID: 31738768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of antifungal combination against Cryptococcus spp.
    Reichert-Lima F; Busso-Lopes AF; Lyra L; Peron IH; Taguchi H; Mikami Y; Kamei K; Moretti ML; Schreiber AZ
    Mycoses; 2016 Sep; 59(9):585-93. PubMed ID: 27135278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment of disseminated cryptococcosis in a liver transplant recipient with fluconazole and flucytosine, an all oral regimen.
    Singh N; Gayowski T; Marino IR
    Transpl Int; 1998; 11(1):63-5. PubMed ID: 9503557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First report of Cryptococcus laurentii meningitis and a fatal case of Cryptococcus albidus cryptococcaemia in AIDS patients.
    Kordossis T; Avlami A; Velegraki A; Stefanou I; Georgakopoulos G; Papalambrou C; Legakis NJ
    Med Mycol; 1998 Oct; 36(5):335-9. PubMed ID: 10075504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluconazole plus flucytosine is a good alternative therapy for non-HIV and non-transplant-associated cryptococcal meningitis: A retrospective cohort study.
    Li Z; Liu Y; Chong Y; Li X; Jie Y; Zheng X; Yan Y
    Mycoses; 2019 Aug; 62(8):686-691. PubMed ID: 31120606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of fluconazole singly and in combination with 5-fluorocytosine or amphotericin B in the treatment of cryptococcal meningoencephalitis in an intracranial murine model.
    Hossain MA; Mukherjee PK; Reyes G; Long L; Ghannoum MA
    J Chemother; 2002 Aug; 14(4):351-60. PubMed ID: 12420852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of cryptococcosis in and around Chandigarh, India, during the period 1982-91.
    Chander J; Sapra RK; Talwar P
    Mycoses; 1994; 37(1-2):23-6. PubMed ID: 7935587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined therapy with fluconazole and flucytosine in murine cryptococcal meningitis.
    Allendoerfer R; Marquis AJ; Rinaldi MG; Graybill JR
    Antimicrob Agents Chemother; 1991 Apr; 35(4):726-9. PubMed ID: 2069378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.